Drugs / Autologous Platelet-Rich Fibrin
Autologous Platelet-Rich Fibrin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07294612 | Jan 2022 → Jan 2025 | exstrophy-epispadias complex | National Children's Medical Center, Uzbekistan | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Platelet-Rich Fibrin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07294612 ↗ |
| Known as | platelet rich fibrin | “Platelet-rich fibrin (PRF) has been shown to have structural and biological properties that promote tissue healing.” PMID 24325905 ↗ Nov 2013 |
| Known as | PRF | “Platelet-rich fibrin (PRF) has been shown to have structural and biological properties that promote tissue healing.” PMID 24325905 ↗ Nov 2013 |